Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One common respiratory ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a ...

Most people experience mild RSV reinfections throughout their lifetime, particularly during respiratory virus season (November to March in Canada). People are at higher risk if they are older than 75 ...

Respiratory syncytial virus (RSV) is a common virus that usually causes mild, cold-like symptoms. You may have heard of ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Clinicians and healthcare professionals should target adults aged 70 and over with underlying health conditions instead of the general population, when it comes to efforts to reduce spending and ...

The respiratory syncytial virus (RSV) can be particularly dangerous for older people with chronic medical conditions. Each ...

Vaccination effectiveness did not differ with inverse probability of vaccination weighting or for those aged 60 to 74 years and 75 years and older ...

As RSV season approaches, it can be hard to separate fact from fiction. News On 6 Anchor LeAnne Taylor shares what to know in this morning's Medical Minute.

The NHS has started vaccinating pregnant women and older people against a respiratory virus that can make some seriously ill.

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study in ...